TP53 and undifferentiated carcinoma: Regarding genetic mutations in TAS, some reports indicate a lower frequency of TP53 and TERT promoter mutations, which are commonly observed in undifferentiated carcinoma, while the incidence of PIK3CA mutations is comparable.